Printer Friendly

Browse Monoclonal antibodies topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Gorillas at US zoo being treated for COVID. Sep 13, 2021 364
Purple Biotech to present overview of ongoing Phase 1b/2 trial of CM24. Sep 13, 2021 378
Celldex initiates CDX-0159 subcutaneous formulation study. Sep 13, 2021 166
First Patient with Celiac Disease Dosed in anti-Interleukin-15 (IL-15) Monoclonal Antibody CALY-002 Phase 1b Trial. Sep 10, 2021 653
Spikimm and Institut Pasteur reveals SPKM001 effectively neutralizes the COVID-19 Delta and Delta Plus Variants. Sep 9, 2021 154
Spikimm and Institut Pasteur reveals SPKM001 effectively neutralizes the COVID-19 Delta and Delta Plus Variants. Sep 9, 2021 155
Spikimm, Institut Pasteur Say SPKM001 Anti-SARS-CoV-2 Human Monoclonal Antibody Effectively Neutralizes the Delta and Delta Plus Variants. Sep 8, 2021 431
Jasper Therapeutics Initiates New Clinical Trial with National Cancer Institute to Evaluate JSP191 in GATA2-related Myelodysplastic Syndromes. Sep 8, 2021 462
Precision BioSciences, Tiziana Life Sciences enter foralumab license agreement. Sep 2, 2021 192
AC Immune announces data from Lauriet Phase 2 study of semorinemab. Clinical report Aug 31, 2021 346
Ligand's partner Gloria Biosciences gets China approval for Zimberelimab in cHL. Aug 30, 2021 181
Edesa gives update on clinical study on monoclonal antibody candidate for Covid. Clinical report Aug 26, 2021 189
Brii Biosciences' ACTIV-2 interim Phase 3 demonstrate significant reduction in the endpoint of hospitalisations or death among non-hospitalised people with mild COVID-19. Aug 25, 2021 221
Brii Biosciences' ACTIV-2 interim Phase 3 demonstrate significant reduction in the endpoint of hospitalisations or death among non-hospitalised people with mild COVID-19. Aug 25, 2021 220
Vir Biotechnology announces first marketing authorization for sotrovimab. Aug 23, 2021 287
COVID-19 | UK APPROVES MONOCLONAL ANTIBODY COCKTAILS, SAR AWAITS SAFETY DATA. Aug 23, 2021 528
Routes and barriers associated with protein and peptide drug delivery system. Saeed, Saba; Irfan, Mavra; Naz, Saima; Liaquat, Momil; Jahan, Shafaq; Hayat, Sana Report Aug 23, 2021 5076
Corona wonder drug treatment approved; Ronapreve could prevent hospitals being overwhelmed. MARTIN BAGOT Aug 21, 2021 484
Britain approves 'first of its kind' Covid treatment to help hospitals fight virus; We'll be bringing you the very latest updates, pictures and video on this breaking news story. By, Martin Bagot Aug 20, 2021 518
Coeptis Therapeutics and VyGen-Bio partner to co-develop two assets designed to improve CD38-related cancer treatment. Aug 20, 2021 183
Coeptis Therapeutics and VyGen-Bio partner to co-develop two assets designed to improve CD38-related cancer treatment. Aug 20, 2021 182
AstraZeneca's antibody therapy prevents Covid-19, study shows. Reuters News Service Drug overview Aug 20, 2021 518
Adagene announces third clinical trial collaboration with Merck. Aug 19, 2021 196
Incyte, InnoCare Ink Collaboration and License Agreement for Tafasitamab in Greater China. Aug 16, 2021 494
Eli Lilly says ADvocate 1, ADvocate 2 trials met primary and secondary endpoints. Aug 16, 2021 432
Bio-Thera Solutions Heralds the Discovery of a Broad-Spectrum SARS-CoV-2 Neutralizing Antibody with Potential to Treat Many Known Variants of COVID-19. Aug 11, 2021 345
PhaseBio announces approval of bentracimab IND. Aug 10, 2021 172
Akeso's Penpulimab receives China regulatory marketing approval. Aug 6, 2021 260
Akeso's Penpulimab receives China regulatory marketing approval. Aug 6, 2021 259
Promega and Henlius Developing Microsatellite Instability Companion Diagnostic IVD Kit for Serplulimab in China. Aug 6, 2021 675
Abcentra doses first patients in multi-centre phase two orticumab trial. Aug 5, 2021 187
Abcentra doses first patients in multi-centre phase two orticumab trial. Aug 5, 2021 188
Health min.: Egypt contracts to receive Bamlanivimab|etesevimab for coronavirus treatment. Egypt Today staff Aug 5, 2021 249
Vir Biotechnology reports Q2 EPS 46c, consensus (48c). Financial report Aug 5, 2021 201
GSK Wins US FDA approval for Nucala for Use in Adults with Chronic Rhinosinusitis with Nasal Polyps. Aug 4, 2021 647
Avidity Biosciences's IND for Phase 1/2 trial of AOC in DM1 cleared by FDA. Aug 2, 2021 217
US FDA approves new Alzheimer's drug: A tortuous history and uncertain benefits have led to controversy over its approval. Aug 1, 2021 214
Potential neuroprotective of trans-resveratrol a promising agent tempeh and soybean seed coats-derived against beta-amyloid neurotoxicity on primary culture of nerve cells induced by 2-methoxyethanol/Potencial neuroprotetor do agente trans-resveratrol em cascas de sementes de soja e tempe derivadas da neurotoxicidade beta-amiloide na cultura primaria de celulas nervosas induzidas pelo 2-metoxietanol. Irnidayanti, Y.; Sutiono, D.R.; Ibrahim, N.; Wisnuwardhani, P.H.; Santoso, A. Aug 1, 2021 4763
GlaxoSmithKline wins FDA approval for Nucala for treating patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Jul 30, 2021 266
GlaxoSmithKline wins FDA approval for Nucala for treating patients with chronic rhinosinusitis with nasal polyps (CRSwNP). Jul 30, 2021 267
TFF Pharmaceuticals, Augmenta Bioworks announce in vitro data on AUG-3387. Jul 29, 2021 294
EU signs deal with GSK for supply of 220,000 treatments of its COVID-19 drug. Jul 28, 2021 151
Cerecor announces initial results from CERC-002 trial. Jul 26, 2021 385
ImmunoPrecise Antibodies' multi-antibody cocktail TATX-03 demonstrates strong efficacy against SARS-CoV-2 Delta variant. Jul 23, 2021 176
ImmunoPrecise Antibodies' multi-antibody cocktail TATX-03 demonstrates strong efficacy against SARS-CoV-2 Delta variant. Jul 23, 2021 175
ImmunoPrecise's PolyTope TATX-03 Antibody Cocktail Potently Neutralizes SARS-CoV-2 Delta Variant in in vitro Pseudovirus Assays. Jul 23, 2021 360
Acticor Biotech Completes Enrollment in its GARDEN Clinical Trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study. Clinical report Jul 23, 2021 449
Abveris signs antibody discovery collaboration with Foundery Innovations. Jul 22, 2021 165
Abveris signs antibody discovery collaboration with Foundery Innovations. Jul 22, 2021 164
Adagene announces clinical trial collaboration with Merck. Jul 22, 2021 258
ImmunoPrecise Antibodies reports TATX-03 neutralizes SARS-CoV-2 Delta variant. Jul 22, 2021 231
Catalent plans USD100m investment to expand COVID-19 vaccine plant in Italy. Jul 21, 2021 190
Catalent plans USD100m investment to expand COVID-19 vaccine plant in Italy. Jul 21, 2021 189
Sorrento says Mabpharm receives marketing approval for infliximab biobetter. Jul 20, 2021 238
Aridis, AstraZeneca announce license agreement for suvratoxumab. Jul 19, 2021 162
Celltrion's Monoclonal Antibody Treatment for COVID-19 Demonstrates Strong Neutralising Activity Against Delta Variant. Jul 16, 2021 562
Innovent Biologics collaborates with Ascentage Pharma. Jul 15, 2021 183
Innovent Biologics collaborates with Ascentage Pharma. Jul 15, 2021 184
Celldex presents 'positive' data from CDX-0159 phase 1b study. Jul 9, 2021 274
Amgen granted Priority Review of tezepelumab for treatment of asthma. Disease/Disorder overview Jul 8, 2021 228
Amgen granted Priority Review of tezepelumab for treatment of asthma. Disease/Disorder overview Jul 8, 2021 229
PureTech Inks Clinical Trial and Supply Agreement with BeiGene to Evaluate LYT-200 and Tislelizumab in Patients with Difficult-to-Treat Solid Tumors. Jul 8, 2021 641
Eucure Biopharma's YH001 and YH003 receive US FDA phase II clinical trial approval. Jul 7, 2021 258
Eucure Biopharma's YH001 and YH003 receive US FDA phase II clinical trial approval. Jul 7, 2021 257
PureTech in clinical trial supply pact with BeiGene to evaluate tislelizumab. Jul 7, 2021 299
Vaccines found to be less effective against Epsilon strain of COVID-19. By: Times News Service Jul 5, 2021 303
GSK and Vir's sotrovimab shows promise in trial. Jul 5, 2021 652
GSK, Alector announce global collaboration in immuno-neurology. Jul 2, 2021 347
Alector, GlaxoSmithKline announce global collaboration for AL001, AL101. Jul 2, 2021 263
XTX101 FDA APP ACCEPTED FOR SOLID TUMORS TREATMENT. Jul 1, 2021 427
Treatment with Radiopharmaceuticals and Radionuclides in Breast Cancer: Current Options. Gulec, Burcu Altiparmak; Yurt, Fatma Report Jul 1, 2021 4753
Acticor Biotech Completes Enrollment in ACTIMIS, its Key Phase 1b/2a Safety Study. Jul 1, 2021 468
I-Mab announces multiple advancements of 4-1BB bispecific antibody portfolio. Jul 1, 2021 159
Immunoassay analyzers for labs of all sizes. Williams, Marisa L. Jul 1, 2021 1422
Cullinan receives FDA clearance of IND application for CLN-619. Jun 29, 2021 180
Horizon says 1st patient enrolled in systemic lupus erythematosus trial. Jun 29, 2021 171
Sensei reprioritizes pipeline programs to focus on product candidates. Jun 28, 2021 267
The FDA authorises the emergency use of Actemra for the treatment of certain hospitalized patients with COVID-19. Jun 25, 2021 265
The FDA authorises the emergency use of Actemra for the treatment of certain hospitalized patients with COVID-19. Jun 25, 2021 264
U.S. 'immediately pausing' distribution of Lilly's Covid monoclonal antibodies. Jun 25, 2021 173
New clinic to treat Covid cases inaugurated. Jun 22, 2021 318
Augmenta, TFF Pharmaceuticals select AUG-3387 to develop against COVID-19. Jun 22, 2021 179
GSK, Vir Biotechnology report results from Phase 3 study of sotrovimab. Jun 21, 2021 568
Bristol Myers Squibb signs global strategic collaboration for Eisai's MORAb-202 antibody drug conjugate. Jun 21, 2021 262
Bristol Myers Squibb signs global strategic collaboration for Eisai's MORAb-202 antibody drug conjugate. Jun 21, 2021 263
Xilio Therapeutics Gains FDA Acceptance of IND Application for XTX101 for the Treatment of Solid Tumors. Jun 18, 2021 344
Taiwan adds COVID therapies to cut severe illness, death rates. Jun 18, 2021 211
TG Therapeutics announces preclinical, clinical data evaluating TG-1701. Jun 18, 2021 370
PhaseBio Inks European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab. Jun 17, 2021 851
Abu Dhabi global first to get new anti-Covid medication. Jun 17, 2021 803
Tiziana Life Sciences submits grant to UK-CTAP to support Foralumab development. Jun 17, 2021 157
Biogen announces first patient dosed in phase 3 clinical study of TOPAZ-1. Clinical report Jun 17, 2021 262
PhaseBio enters exclusive bentracimab licensing agreement with Alfasigma. Jun 17, 2021 225
ImmunoPrecise says antibodies program reduces lung inflammation. Jun 17, 2021 228
Regeneron announces UK RECOVERY trial meets primary outcome. Jun 16, 2021 553
Eli Lilly announces Emgality, Nurtec ODT head-to-head study. Jun 15, 2021 186
GlaxoSmithKline snaps up promising cancer treatment ahead of crunch investor day. Jun 15, 2021 405
TOP NEWS: GlaxoSmithKline in USD2.1 billion cancer treatment tie-up. Jun 14, 2021 307
iTeos Therapeutics, GlaxoSmithKline collaborate for EOS-448. Jun 14, 2021 195
TG Therapeutics announces data from Phase 1 study of TG-1701. Jun 11, 2021 322
Eitan Medical uses MPP Infusion Centres in sapphire infusion pumps to administer COVID-19 treatments. Jun 10, 2021 226
Eitan Medical uses MPP Infusion Centres in sapphire infusion pumps to administer COVID-19 treatments. Jun 10, 2021 227
Bio-Thera Solutions Initiates Phase III Clinical Trial for BAT2506, a Proposed Biosimilar of Simponi. Jun 9, 2021 285
Kiniksa reports defined regulatory pathway for Phase 3 mavrilimumab development. Jun 8, 2021 482
Chinook Therapeutics presents BION-1301 interim phase 1/2 data. Jun 8, 2021 414
SpringsWorks, Seagen enter collaboration for nirogacestat w/ SEA-BCMA. Jun 7, 2021 200
Purple Biotech presents new clinical data from NT219. Jun 4, 2021 308
TG Therapeutics announces data from Phase 1 study of TG-1701. Jun 4, 2021 328
Eli Lilly presents data from OVERCOME study at AHS. Jun 3, 2021 312
IGM Biosciences announces expansion of IgM platform into infectious diseases. Jun 3, 2021 296
New drug for Covid-19 treatment approved. Jun 3, 2021 231
Houston Methodist partners with U.S. Department of Health and Human Services to expand access to COVID-19 monoclonal antibody treatment. Jun 2, 2021 231
Houston Methodist partners with U.S. Department of Health and Human Services to expand access to COVID-19 monoclonal antibody treatment. Jun 2, 2021 230
Karyopharm's nexpovio receives conditional marketing authorization in U.K. Jun 2, 2021 166
Skylight Health announces award of US clinical trial. Jun 2, 2021 214
Amgen, Kyowa Kirin to jointly develop, commercialize KHK4083. Jun 1, 2021 227
Corbus Pharmaceuticals licenses two integrin targeting mAbs. Jun 1, 2021 159
CStone Pharmaceuticals' sugemalimab meets primary endpoint in first-in-class registration clinical trial. Jun 1, 2021 186
Theradiag introduces HUMABDIAG for bioproduction of monoclonal antibodies research in Tours. Jun 1, 2021 233
CStone Pharmaceuticals' sugemalimab meets primary endpoint in first-in-class registration clinical trial. Jun 1, 2021 187
Theradiag introduces HUMABDIAG for bioproduction of monoclonal antibodies research in Tours. Jun 1, 2021 234
US Investment bank repeats 'buy' and US$8 price target on Tiziana Life Sciences after flurry of positive news. May 29, 2021 328
US Investment bank repeats 'buy' and US$8 price target on Tiziana Life Sciences after flurry of positive news. May 29, 2021 328
Zacks Small-Cap Research repeats its valuation on Tiziana Life Sciences as company starts nasally administered Foralumab trial for SPMS. May 28, 2021 336
GlaxoSmithKline receives US emergency authorisation for COVID-19 treatment. May 28, 2021 416
Zacks Small-Cap Research repeats its valuation on Tiziana Life Sciences as company starts nasally administered Foralumab trial for SPMS. May 28, 2021 336
CStone Pharmaceuticals's sugemalimab meets primary endpoint for stage III lung cancer testing. May 28, 2021 192
CStone Pharmaceuticals's sugemalimab meets primary endpoint for stage III lung cancer testing. May 28, 2021 193
US regulator authorises GSK and Vir's sotrovimab for Covid treatment. May 27, 2021 229
GlaxoSmithKline receives emergency use authorisation from USFDA for Sotrovimab. May 27, 2021 176
GlaxoSmithKline receives emergency use authorisation from USFDA for Sotrovimab. May 27, 2021 175
Tiziana Life hails 'major accomplishment as nasally administered antibody shows potential to treat degenerative diseases such as MS. May 27, 2021 288
Proactive news headlines: Supply@ME Capital, Tiziana Life Sciences, Polarean Imaging, IQGeo Group... May 27, 2021 760
Tiziana Life hails 'major accomplishment as nasally administered antibody shows potential to treat degenerative diseases such as MS. May 27, 2021 288
Tiziana Life Sciences initiates trial using nasally administered monoclonal antibody to treat a person with secondary progressive multiple sclerosis. May 26, 2021 205
Tiziana Life Sciences initiates trial using nasally administered monoclonal antibody to treat a person with secondary progressive multiple sclerosis. May 26, 2021 205
FDA Authorizes Additional Monoclonal Antibody for Treatment of COVID-19. May 26, 2021 576
FDA issues EUA for Vir and GSK's COVID-19 antibody therapy. May 26, 2021 164
Xencor, Bristol-Myers in licensing pact for Xtend XmAb technology. May 25, 2021 261
Avid Bioservices to be commercial manufacturer for ADC Therapeutics' ZYNLONTA. May 25, 2021 168
Covid-19: More evidence that monoclonal antibodies reduce risk of death. May 23, 2021 352
Tiziana Life Sciences confident of advancing drug development pipeline. May 19, 2021 374
Tiziana Life Sciences confident of advancing drug development pipeline. May 19, 2021 374
Celltrion Confirms Neutralising Potency Against Emerging SARS-CoV-2 Variants with Anti-COVID-19 Monoclonal Antibody Treatment regdanvimab (CT-P59). May 18, 2021 410
FDA says data do not support benefit of CytoDyn's leronlimab in treating COVID. May 17, 2021 511
Identification of and Surveillance for the SARS-CoV-2 Variants B.1.427 and B.1.429--Colorado, January-March 2021. Webb, Lindsey Martin; Matzinger, Shannon; Grano, Christopher; Kawasaki, Breanna; Stringer, Ginger; B May 14, 2021 1075
Goldfinch Bio Initiates Phase 1 Clinical Trial of GFB-024, a Novel Precision Medicine Product Candidate for Patients with Severe Insulin Resistant Diabetic Nephropathy. May 13, 2021 457
Labcorp, the US Department of Health and Human Services Team to Raise Awareness of COVID-19 Treatments. May 12, 2021 361
Preclinical Data on HiFiBiO Therapeutics' SARS-CoV-2 Neutralizing Monoclonal Antibody Published in Nature. May 11, 2021 471
Cellectis, Sanofi enter supply, partnership agreement for alemtuzumab. May 11, 2021 186
GlaxoSmithKline, Vir Biotechnology announce rolling EMA review of sotrovimab. May 7, 2021 275
Adagio Therapeutics begins treatment of first patient with ADG20 in COVID-19 EVADE trial. May 6, 2021 241
Adagio Therapeutics begins treatment of first patient with ADG20 in COVID-19 EVADE trial. May 6, 2021 242
Horizon Therapeutics announces publication on inebilizumab-cdon. May 6, 2021 200
Truffle Capital and The Institut Pasteur Create SpikImm to Develop Monoclonal Antibodies as an Innovative Treatment for Covid-19. May 6, 2021 302
Fate Therapeutics reports Q1 EPS (48c), consensus (23c). Financial report May 5, 2021 190
New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials. May 4, 2021 619
Kiniksa announces final data from Phase 1 trial of KPL-404. May 4, 2021 407
ImmunityBio announces publication of Anktiva data. May 4, 2021 173
Cytoreductive stereotactic body radiotherapy (SBRT) and combination SBRT with immune checkpoint inhibitors (ICIs) in metastatic renal cell carcinoma. Peng, Jonathan; Lalani, Aly-Khan; Swaminath, Anand Report May 4, 2021 4747
Celltrion's CT-P59 could be effective against the South African variant and against mutations of the variant. May 3, 2021 243
Celltrion's CT-P59 could be effective against the South African variant and against mutations of the variant. May 3, 2021 242
WATERS INTRODUCES PEPTIDE MULTI-ATTRIBUTE METHOD. May 1, 2021 303
Secukinumab brings high PASI 75 in kids with psoriasis. Jancin, Bruce May 1, 2021 746
Engineered NS1 for Sensitive, Specific Zika Virus Diagnosis from Patient Serology. Yap, Thai Leong; Hong, Shin Yee; Soh, Jun Hui; Ravichandraprabhu, Lekha; Lim, Vanessa W.X.; Chan, Hs Report May 1, 2021 6399
Pathologic Manifestations of Gastrointestinal and Hepatobiliary Injury in Immune Checkpoint Inhibitor Therapy. Patil, Pallavi A.; Zhang, Xuchen Report May 1, 2021 8342
Brii Biosciences Monoclonal Antibodies, BRII-196 and BRII-198, Progress to Phase 3 in NIH ACTIV-2 Trial in Ambulatory COVID-19 Patients. Apr 29, 2021 555
Celltrion's anti-COVID 19 Monoclonal Antibody Treatment Regdanvimab Demonstrates Neutralising Effect Against the South African Cariant. Apr 29, 2021 461
Headaches: The Type Dictates the Treatment: Tension, cluster, and migraine headaches have different symptoms and causes. Apr 28, 2021 888
Immunome's IMM-BCP-01 antibodies effective against the current SARS-CoV-2 and its variants, with IND in late Q2/early Q3 2021. Apr 27, 2021 220
Immunome's IMM-BCP-01 antibodies effective against the current SARS-CoV-2 and its variants, with IND in late Q2/early Q3 2021. Apr 27, 2021 221
Sorrento Therapeutics gets FDA clearance to proceed with Phase 2 Sti-3031 study. Apr 27, 2021 289
Y-mAbs submits Omburtamab MAA to European Medicines Agency. Apr 27, 2021 241
Samsung Biologics expands drug manufacturing with TG Therapeutics. Apr 26, 2021 522
Samsung Biologics expands TG Therapeutics collaboration. Apr 26, 2021 185
Samsung Biologics expands TG Therapeutics collaboration. Apr 26, 2021 186
Immunome SARS-CoV-2 Antibody Cocktail Neutralizes UK, South Africa, Brazil and California Variants in Preclinical Testing. Apr 26, 2021 406
Immunome's antibody cocktail neutralizes three SARS-CoV-2 variants. Apr 26, 2021 168
CHMP Recommends EU Approval of Chugai's Enspryng for Neuromyelitis Optica Spectrum Disorder. Apr 26, 2021 432
Coram chosen for IV therapy. Apr 26, 2021 211
Coherus says Toripalimab achieved primary endpoints in Phase 3 trial. Apr 23, 2021 268
Purple Biotech announces dosing of first patient in Phase 1b/2 trial of CM24. Apr 23, 2021 185
The FDA revokes emergency use authorization for monoclonal antibody bamlanivimab for treating COVID-19. Apr 20, 2021 223
The FDA revokes emergency use authorization for monoclonal antibody bamlanivimab for treating COVID-19. Apr 20, 2021 224
Y-mAbs receives requests from FDA for additional data on omburtamab. Apr 20, 2021 167
Transcenta Holding doses first patient in phase one clinical study of gastric cancer drug. Clinical report Apr 19, 2021 191
Transcenta Holding doses first patient in phase one clinical study of gastric cancer drug. Clinical report Apr 19, 2021 192
Qilu Pharmaceutical, Peptron Ink License Agreement for Anti-MUC1 ADC. Apr 19, 2021 316
TG Therapeutics announces results from ULTIMATE I & II trials of ublituximab. Financial report Apr 16, 2021 433
Horizon Therapeutics announces pooled Tepezza data published. Apr 16, 2021 646
Horizon Therapeutics announces new Uplizna data at AAN. Apr 16, 2021 531
FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab. Apr 16, 2021 538
Injection boost for poor pooches with sore limbs. neil mcintosh Apr 15, 2021 432
Chinook Therapeutics presents data during ISN world congress, first two posters. Clinical report Apr 15, 2021 489
GlaxoSmithKline, Vir Biotechnology announce EMA review of VIR-7831. Apr 15, 2021 194
RubrYc Therapeutics Inks License Option Agreement with Zai Labs. Apr 15, 2021 306
Adagio Therapeutics begins global clinical trial of ADG20 for the treatment of COVID-19. Apr 14, 2021 266
Adagio Therapeutics begins global clinical trial of ADG20 for the treatment of COVID-19. Apr 14, 2021 265
C4X Discovery strikes Sanofi licensing deal worth up to [euro]414mln. Apr 13, 2021 237
Kiniksa announces results for mavrilimumab phase 2 trial in COVID-19 patients. Clinical report Apr 12, 2021 503
NextCure presents preclinical data for NC762 at AACR Annual Meeting. Apr 11, 2021 153
Syndax Pharmaceuticals' axatilimab receives US FDA Orphan Drug Designation. Apr 9, 2021 229
Syndax Pharmaceuticals' axatilimab receives US FDA Orphan Drug Designation. Apr 9, 2021 228
aTyr Pharma presents preclinical research on the effects of ATYR2810. Apr 9, 2021 161
ChemoCentryx announces poster presentation on CCX559. Apr 9, 2021 194
Biogen, Bio-Thera solutions announce commercialization agreement for biosimilar. Apr 8, 2021 167
Vir Biotechnology announces preclinical research on SARS-CoV-2. Apr 8, 2021 455
Shanghai Genechem announces global collaboration with I-Mab. Apr 7, 2021 164
Shanghai Genechem announces global collaboration with I-Mab. Apr 7, 2021 165
Chinook Therapeutics to create Sairopa company through Van Herk transaction. Apr 5, 2021 386
Vir Biotechnology announces preclinical research on VIR-7831. Apr 5, 2021 254
Imported SARS-CoV-2 Variant P.1 in Traveler Returning from Brazil to Italy. Maggi, Fabrizio; Novazzi, Federica; Genoni, Angelo; Baj, Andreina; Spezia, Pietro Giorgio; Focosi, D Clinical report Apr 1, 2021 1057
Tiziana Life Sciences plans phase II trials of nasal antibody treatment in COVID-19 patients. Mar 31, 2021 241
Tiziana Life Sciences shares shoot up after receiving FDA sign-off for use nasally administered monoclonal antibody to treat a person with secondary progressive multiple sclerosis. Mar 31, 2021 321
Tiziana Life Sciences: US investment bank restates its US$8 price and 'buy' recommendation after double dose of good news. Mar 31, 2021 371
Tiziana Life Sciences plans phase II trials of nasal antibody treatment in COVID-19 patients. Mar 31, 2021 241
Tiziana Life Sciences shares shoot up after receiving FDA sign-off for use nasally administered monoclonal antibody to treat a person with secondary progressive multiple sclerosis. Mar 31, 2021 321
Proactive news headlines: Catenae Innovation, LoopUp, ADES International, Westmount Energy... Mar 31, 2021 934
Tiziana Life Sciences: US investment bank restates its US$8 price and 'buy' recommendation after double dose of good news. Mar 31, 2021 371
Tiziana Life Sciences plans further development of Foralumab. Clinical report Mar 30, 2021 235
I-MAB, ABL Bio receive FDA approval to start phase 1 trial of CD4B/ABL11. Mar 30, 2021 165
Tiziana announces FDA allowance of nasal administration with Foralumab. Mar 30, 2021 248
Equillium announces data from Equalise study in patients with SLE. Report Mar 30, 2021 173
European Medicines Committee Issues Advice On the Use of Celltrion's Anti-COVID-19 Monoclonal Antibody Treatment. Mar 29, 2021 472
Adagene announces clinical advancement for ADG116. Mar 29, 2021 403
Karyopharm receives conditional marketing authorization for Nexpovio in EU. Mar 29, 2021 178
US Food and Drug Administration Approves Bristol Myers Squibb's and Bluebird Bio's Abecma for Relapsed or Refractory Multiple Myeloma. Mar 29, 2021 815
FDA approves Bristol Myers Squibb, Bluebird Bio's Abecma. Mar 28, 2021 263
Lassen Therapeutics Teams Cedars Sinai Medical Center to Study the Role of IL-11 Signaling and Inhibition in Preclinical Models of Lung Fibrosis. Mar 26, 2021 264
Equillium reports Q4 EPS (36c), consensus (38c). Financial report Mar 24, 2021 166
CareDx backs Vir Biotechnology's trial recruitment efforts for COMET-ICE. Mar 23, 2021 211
Leap Therapeutics presents clinical data from Phase 2 trial of DKN-01. Mar 22, 2021 514
WORTH NOTING. Gajewski, Karen Ann Mar 22, 2021 820
SCORING BAMLANIVIMAB: COVID MEETS KAFKA IN L.A. COUNTY. Robins, Lisa Mar 22, 2021 2378
Novel approaches: Scientists are exploring innovative new approaches to treating MS. King, Mary E. Mar 22, 2021 1430
Purple Biotech initiates Phase 1b/2 trial of CM24. Mar 19, 2021 163
New Drug Uses Monoclonal Antibodies: Initial research shows frunevetmab may treat arthritis pain. Mar 17, 2021 204
Statins May Mitigate Heart Damage from Cancer Drugs. Mar 17, 2021 188
Companies make progress with COVID antibodies. Mar 15, 2021 1252
GlaxoSmithKline recommended to stop COVID-19 treatment trials early because of high efficacy. Mar 12, 2021 274
Antibody 'cocktails' effective against SARS-CoV-2 mutations. Mar 12, 2021 322
TOP NEWS: GSK, partner Vir chase US emergency use for virus antibody. Mar 11, 2021 184
Brii Biosciences Antibodies Fail to Meet Efficacy Criteria; Combination Will Not Progress into a Phase 3 Study Evaluating the Treatment of SARS-CoV-2 in Hospitalized Patients. Mar 5, 2021 585
EMA Issues Advice on Regeneron's Antibody Cocktail for Certain COVID-19 Patients. Mar 1, 2021 890
Recent advancement on PD-L1 expression quantification: the radiologist perspective on CT-guided FNAC. Casale, Silvia; Bortolotto, Chandra; Stella, Giulia Maria; Filippi, Andrea Riccardo; Gitto, Salvator Report Mar 1, 2021 3869
Clinical characteristics, disease activity, functional status, and quality of life results of patients with psoriatic arthritis using biological and conventional synthetic disease-modifying antirheumatic drugs. Keskin, Yacar; Nas, Kemal; Kilic, Erkan; Sargin, Betul; Kasman, Sevtap Acer; Alkan, Hakan; Sahin, Ni Clinical report Mar 1, 2021 6184
COVID-19: Selected Medicare Resources for Beneficiaries and Health Care Providers. Malloy, Michele L. Mar 1, 2021 580
PD-L1 testing and immunotherapy selection - early laboratory experience and its potential role in head and neck cancer management. Bancu, Andrei; Cowan, Richard; Chaturvedi, Anshuman Mar 1, 2021 2047
Tocilizumab-induced anaphylaxis in two patients with COVID-19-induced cytokine storm. Training, Konya Clinical report Mar 1, 2021 2378
A Pathophysiological and Pharmacological Review on Alzheimer's Disease: A Current Need. Sheela, D.; Rohan, R. Disease/Disorder overview Mar 1, 2021 3607
Illness episodes in a cohort of preterm infants in their first year of life. Muller, S.J.; Zar, H.J.; Tooke, L. Mar 1, 2021 4258
GlaxoSmithKline tweaks COVID-19 treatment study after missing primary goal. Clinical report Feb 26, 2021 289
New COVID-19 virus variant discovered in New York City and Northeast US. Feb 25, 2021 289
New COVID-19 virus variant discovered in New York City and Northeast US. Feb 25, 2021 285
ImmunoPrecise Releases Data from Preclinical Study of TATX-03 PolyTope Monoclonal Antibody Cocktail Candidate Against COVID-19. Feb 19, 2021 693
TOP NEWS: GSK, Vir Expand Deal To Include New Influenza Therapies. Feb 17, 2021 262
Jasper Therapeutics Launches New Clinical Trial with National Heart, Lung, and Blood Institute to Evaluate JSP191 in Sickle Cell Disease. Feb 16, 2021 520
First Patient Dosed in Phase 1 Trial of Adagio Therapeutics' ADG20 Lead Monoclonal Antibody Candidate for the Treatment and Prevention of COVID-19. Feb 16, 2021 197
Sagent Pharmaceuticals adds Camostat mesilate to ACTIV-2 Adaptive Platform Treatment Trial for COVID-19. Feb 15, 2021 207
Sagent Pharmaceuticals adds Camostat mesilate to ACTIV-2 Adaptive Platform Treatment Trial for COVID-19. Feb 15, 2021 203
Celltrion develops neutralising antibody cocktail CT-P59 for the treatment of COVID-19 Variant mutations, including the UK and six other variant genome mutations. Feb 11, 2021 253
Celltrion develops neutralising antibody cocktail CT-P59 for the treatment of COVID-19 Variant mutations, including the UK and six other variant genome mutations. Feb 11, 2021 249
Celltrion Develops Tailored Neutralising Antibody Cocktail Treatment with CT-P59 to Tackle COVID-19 Variant Spread Using Its Antibody Development Platform. Feb 11, 2021 560
Celltrion Group receives CMA from the Korean Ministry of Food and Drug Safety for CT-P59 for treating COVID-19 in adult patients. Feb 8, 2021 311
Celltrion Group receives CMA from the Korean Ministry of Food and Drug Safety for CT-P59 for treating COVID-19 in adult patients. Feb 8, 2021 307
AstraZeneca Says Imfinzi Did Not Meet Primary Endpoint In Cancer Trial. Feb 5, 2021 223
Celltrion's COVID-19 Treatment Candidate Receives Korean MFDS Conditional Marketing Authorisation. Feb 5, 2021 247
South Korea OKs Celltrion's COVID-19 treatment for conditional use. Feb 5, 2021 257
Tiziana Life Sciences: HC Wainwright analyst flags the "intriguing evidence of therapeutic utility" for nasally administered Covid antibody treatment. Feb 4, 2021 503
Tiziana Life Sciences: HC Wainwright analyst flags the "intriguing evidence of therapeutic utility" for nasally administered Covid antibody treatment. Feb 4, 2021 505
Medical regulators in Italy approve two monoclonal antibodies for COVID-19 treatment. Feb 4, 2021 180
Tiziana Life Sciences hails positive results from Brazil coronavirus study of breakthrough nasally-administered antibody treatment. Feb 3, 2021 558
Tiziana Life Sciences: US investment bank restates its US$8 price and 'buy' recommendation after results from Brazil study of Covid antibody treatment. Feb 3, 2021 527
Tiziana Life Sciences hails positive results from Brazil coronavirus study of breakthrough nasally-administered antibody treatment. Feb 3, 2021 556
Tiziana Life Sciences hails positive results from Brazil coronavirus study of breakthrough nasally-administered antibody treatment. Feb 3, 2021 560
Tiziana Life Sciences: US investment bank restates its US$8 price and 'buy' recommendation after results from Brazil study of Covid antibody treatment. Feb 3, 2021 529
Proactive news headlines:AaInnovaderma,AaTiziana Life Sciences,AaSureserve Group,AaGfinity ... Feb 3, 2021 1887
Humanigen, Avid Bioservices Enter Into cGMP Manufacturing Agreement for COVID-19 Therapeutic Candidate Lenzilumab in Support of Potential EUA Filing. Feb 3, 2021 512
Bristol Myers Squibb Licenses The Rockefeller University's SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19. Feb 3, 2021 527
European Medicines Agency committee adopts positive opinion recommending the conditional approval for Karyopharm Therapeutics' NEXPOVIO. Feb 1, 2021 253
European Medicines Agency committee adopts positive opinion recommending the conditional approval for Karyopharm Therapeutics' NEXPOVIO. Feb 1, 2021 249
OSE EXPANDS COLLABORATION WITH MABSILICO. Feb 1, 2021 685
TOP 5: Pediatric dermatology stories of 2020. Bosworth, Ted Feb 1, 2021 1077
BioInvent releases positive Phase I/IIa data from non-Hodgkin's lymphoma trial. Jan 28, 2021 168
BioInvent releases positive Phase I/IIa data from non-Hodgkin's lymphoma trial. Jan 28, 2021 167
BioInvent releases positive Phase I/IIa data from non-Hodgkin's lymphoma trial. Jan 28, 2021 163
First Patient Dosed in European Union as Part of REVERSE-IT Global Phase 3 Trial of Bentracimab for Reversal of Antiplatelet Effects of Ticagrelor. Jan 28, 2021 672
US FDA Accepts Biologics License Application for BAT1706, a Proposed Biosimilar to Avastin. Jan 28, 2021 351
Biologics License Application Accepted in China for Sylvant. Jan 26, 2021 273
Care Access Research Collaborates with AstraZeneca on Phase III Clinical Trial for COVID-19 Long-Acting Antibody Combination. Jan 26, 2021 298
MorphoSys, I-Mab Dose First Patient In Phase One Study Of Cancer Drug. Jan 26, 2021 223
Adagio Therapeutics Publishes Preclinical Data in Science Demonstrating Best-in-class Breadth and Potency Against SARS-CoV-2, Including Known Circulating Resistance Variants, and a Range of Pre-Emergent Coronaviruses. Jan 26, 2021 192
Celltrion Group Touts Positive Top-Line Efficacy and Safety Data from Global Phase II/III Clinical Trial of COVID-19 Treatment Candidate CT-P59. Jan 13, 2021 610
Jasper Therapeutics and Graphite Bio Collaborate to Evaluate JSP191 as Conditioning Regimen for Novel Gene Replacement Therapy in Patients with XSCID. Jan 13, 2021 666
AvantGen Licenses Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development. Jan 12, 2021 488
TOP NEWS: GSK, Vir To Probe Second Virus Antibody In NHS-Backed Trial. Jan 12, 2021 291
Humanigen partners with EVERSANA to support the launch of Lenzilumab for the treatment of SARS-CoV-2 infection. Jan 11, 2021 194
Humanigen partners with EVERSANA to support the launch of Lenzilumab for the treatment of SARS-CoV-2 infection. Jan 11, 2021 198
Humanigen, Eversana Partner Support the Launch and Commercialization of Lenzilumab for the Treatment of COVID-19. Jan 11, 2021 398
Sanofi To Buy Biopharmaceutical Firm Kymab For Up To USD1.45 Billion. Jan 11, 2021 241

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |